News General
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
March 27, 2020 - Breda
The clinical specialists at Werfen are currently following scientific papers related to COVID-19 and it consequences on health and take in care. Open-access papers that might interest you will be gathered in different news items on our website and can also be downloaded from the journals websites.
Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. Journal of Thrombosis and Haemostasis 2020 doi: 10.1111/jth.14810
The aim of this guidance document is to provide a risk stratification at admission for a COVID-19 patient and management of coagulopathy which may develop in some of these patients, based on easily available laboratory parameters.
In patients who develop sepsis from various infectious agents, development of coagulopathy is one of the key and persistent features which is associated with poor outcomes. In this context, the role of International Society of Thrombosis and Haemostasis (ISTH) would be crucial in guiding health care professionals how to manage the coagulopathy of COVID-19. The aim of this guidance document is to provide a risk stratification at admission for a COVID-19 patient and management of coagulopathy which may develop in some of these patients, based on easily available laboratory parameters.
This pragmatic statement should clearly be considered as an interim guidance since the clinical experience of managing this pandemic is increasing. The authors are certain that this statement will be modified with developing knowledge and therapeutics in managing COVID-19.
NEWS
Latest News
April 20, 2020 - Breda
Contact us directly filling out the form below.
Belgium-Luxembourg
infobnl@werfen.com
Tel: +32 (0) 800 713 37
The Netherlands
infobnl@werfen.com
Tel: +31 (0) 800 882 02 88